Pharma News

After cardiac stents, 14 more medical devices could see price regulation

  • Posted on: 21 February 2017
  • By: Shalini.Sharma

The National Pharmaceutical Pricing Authority (NPPA) has begun scrutiny of such devices, even asking makers to log in every detail about their manufacture and cost. After cardiac stents, about 14 medical devices increasingly sold at inflated prices in hospitals could see price regulation in the months to come. The list includes orthopedic implants, intraocular lenses and artificial heart valves to consumables such as syringes, needles and catheters.


Pharma industry escapes the push of Donald Trump for a radical change to the FDA

  • Posted on: 17 February 2017
  • By: Shalini.Sharma

The prospect of a major change to the regulatory agency comes as drug makers are under fire for high prices, including Marathon Pharmaceuticals LLC, which said  "stop" the launch of its drug Duchenne muscular dystrophy after American lawmakers questioned her $ 89,000 a year award.


Government sets 'tough' targets for reducing IMR, MMR

  • Posted on: 17 February 2017
  • By: Shalini.Sharma

The Union health ministry said it set "tough" targets to reduce infant and maternal mortality rates, which are already at a faster pace than the global rate.


US pharmaceutical industry demand to keep India in patent violator list

  • Posted on: 16 February 2017
  • By: Shalini.Sharma

Among the main concerns of the US pharmacy sector in India are the unpredictable IP environment, high tariffs and drug taxes, failure of regulatory data protection, access policies Discriminatory and non-transparent markets and the unpredictable environment for clinical research.


NPPA mandates the rule to hospitals to prepare stents invoice separately

  • Posted on: 16 February 2017
  • By: Shalini.Sharma

The National Pharmaceutical Pricing Authority (NPPA) made it mandatory for these facilities to disclose separately the cost of the stent when charging a patient. Medical facilities, including retailers and resellers of stents, should also display the price list of stents on a part of their premises that is easily accessible to anyone wishing to consult the same.


Government will soon delinked Medical device industry from the pharma sector

  • Posted on: 16 February 2017
  • By: Shalini.Sharma

The medical device will soon be disconnected from the pharmaceutical sector so that it can draw a separate and definitive line with a framework facilitating regulatory framework, said Union Minister for Chemicals, Ananth Kumar at Indian Pharma and Indian Medical Devices International Conference in the city.


Pages